Updated:
DSM Venturing
DSM Venturing was established in 2001 as the venture capital arm of DSM. It focuses on early-stage and growth investments without a disclosed family wealth...
DSM Venturing
DSM Venturing was established in 2001 as the venture capital arm of DSM. It focuses on early-stage and growth investments without a disclosed family wealth origin. The firm targets biotechnology, healthcare, renewable energy, food, and chemicals. It participates in seed through expansion rounds and maintains a worldwide footprint that includes operations in Europe, Asia, and additional locations. Confirmed sector coverage spans biopolymers and consumer products. No recent operational events from the last 24 months appear in available records. Team size and adjacent vehicles remain undisclosed. The structure operates as a corporate venture unit rather than an independent family office or multi-strategy manager.
General information
Firm type
Private Equity
Year founded
2001
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Kaiseraugst
Corporate office
Wurmisweg 576, 4303 Kaiseraugst, Switzerland
Additional offices
Valletta · Tokyo
Sector focus
Frequently asked questions
Who runs investment decisions at DSM Venturing?
No named principals or CIO appear in public records or the firm site.
How does DSM Venturing source proprietary deal flow?
The unit draws from DSM corporate networks in nutrition and materials. Specific sourcing methods are not detailed publicly.
Does DSM Venturing participate in fund commitments or only direct deals?
The firm takes direct minority stakes in portfolio companies across venture stages.
What investment stages does DSM Venturing typically target?
It covers seed, start-up, early stage, growth, and expansion rounds.
Where does the underlying capital come from?
Capital originates from DSM corporate resources rather than external LPs or family wealth.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: